{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:19:38Z","timestamp":1782883178062,"version":"3.54.5"},"reference-count":86,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"European Union \u2013 Next Generation EU \u2013 PNRR M6C2","award":["PNRR-MAD-2022-12375795"],"award-info":[{"award-number":["PNRR-MAD-2022-12375795"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2026,4,27]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To summarise the evidence so far from all randomised controlled trials on the efficacy of communication of polygenic risk scores in changing health outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Cochrane Central Register of Controlled Trials (CENTRAL) and Pubmed, from inception to 1 March 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria for selecting studies<\/jats:title>\n                    <jats:p>Randomised controlled trials in human participants; articles published or accepted for publication in peer reviewed journals, or with available results on ClinicalTrials.gov, without time restriction in any language; and randomised controlled trials comparing the disclosure of inherited genetic risk obtained through the polygenic risk score for any phenotype (intervention group) with scenarios where no genetic information was provided (comparator group).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 7830 articles retrieved, 27 randomised controlled trials were eligible for inclusion in the analysis. Polygenic risk scores mainly predicted risks for cancer (n=9 randomised controlled trials), cardiovascular diseases (n=8), and diabetes (n=6). 21 randomised controlled trials targeted mainly healthy populations, three targeted at-risk populations, and three trials targeted individuals who had already developed a disease and the polygenic risk score predicted complications. Most randomised controlled trials (15\/27) concluded in their abstracts with favourable claims about the polygenic risk score, with only 5\/15 trials justifying the score with any significant results. Nine of the 27 randomised controlled trials had a high risk of bias. Meta-analysis showed no significant effects on any of the 22 outcomes tested in two or more trials. Standardised mean differences for dietary outcomes were \u22120.11 (95% confidence interval\u2009(CI) \u22120.22 to 0.01) for daily energy intake, 0.03 (\u22120.18 to 0.25) for daily fat intake, and \u22120.11 (\u22120.28 to 0.06) for alcohol consumption. For physical activity, standardised mean difference was \u22120.01 (95%\u2009CI \u22120.13 to 0.11). Relative risks were 1.12 (95%\u2009CI 0.77 to 1.61) for screening attendance, 1.50 (0.98 to 2.29) for use of statins, and 0.95 (0.32 to 2.79) for incidence of disease. For psychological outcomes, standardised mean differences were \u22120.02 (95%\u2009CI \u22120.13 to 0.08) for anxiety, \u22120.06 (\u22120.23 to 0.10) for worry, \u22120.04 (\u22120.21 to 0.13) for perceived risk, and \u22120.05 (\u22120.23 to 0.13) for depression. For clinical outcomes, mean differences were \u22122.01 (95%\u2009CI \u22128.27 to 4.26) for total cholesterol, \u22123.64 (\u22127.88 to 0.60) for low density lipoprotein cholesterol, \u22120.21 (\u22122.65 to 2.23) for high density lipoprotein cholesterol, \u22121.88 (\u22124.17 to 0.42) for diastolic blood pressure, \u22121.26 (\u22124.44 to 1.92) for systolic blood pressure, \u22120.12 (\u22120.63 to 0.39) for body mass index, and \u22120.33 (\u22120.87 to 0.20) for weight. 80 outcomes were reported across multiple studies, with each outcome reported in a single trial only. 19 of 80 were primary outcomes, and of these two had significant results (P&lt;0.05), as did three secondary outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, despite frequent promising claims, disclosure of polygenic risk scores did not result in meaningful changes in behavioural, psychological, or clinical measures for the outcomes examined. Although when interpreting the findings the heterogeneity and methodological limitations of the available trials should be considered, communication of polygenic risk scores did not show consistent improvements in preventive behaviours or risk factor modification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>Open Science Framework doi.org\/10.17605\/OSF.IO\/28V6J<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjmed-2025-002347","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:00:15Z","timestamp":1781265615000},"page":"e002347","source":"Crossref","is-referenced-by-count":1,"title":["Effects of polygenic risk score communication on short term health outcomes: systematic review and meta-analysis"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5015-2725","authenticated-orcid":false,"given":"Luigi","family":"Russo","sequence":"first","affiliation":[{"name":"Section of Hygiene, Department of Life Sciences and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3111-1535","authenticated-orcid":false,"given":"Nicol\u00f2","family":"Lentini","sequence":"additional","affiliation":[{"name":"Section of Hygiene, Department of Life Sciences and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Farina","sequence":"additional","affiliation":[{"name":"Section of Hygiene, Department of Life Sciences and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cristiano","sequence":"additional","affiliation":[{"name":"Section of Hygiene, Department of Life Sciences and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9427-578X","authenticated-orcid":false,"given":"Andrea","family":"Adduci","sequence":"additional","affiliation":[{"name":"Section of Hygiene, Department of Life Sciences and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Perilli","sequence":"additional","affiliation":[{"name":"Section of Hygiene, Department of Life Sciences and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Cao","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5013-0733","authenticated-orcid":false,"given":"Roberta","family":"Pastorino","sequence":"additional","affiliation":[{"name":"Section of Hygiene, Department of Life Sciences and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"},{"name":"Department of Woman and Child Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1864-749X","authenticated-orcid":false,"given":"Stefania","family":"Boccia","sequence":"additional","affiliation":[{"name":"Section of Hygiene, Department of Life Sciences and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"},{"name":"Department of Woman and Child Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3118-6859","authenticated-orcid":false,"given":"John PA","family":"Ioannidis","sequence":"additional","affiliation":[{"name":"Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, CA, USA"},{"name":"Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA"},{"name":"Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2026061205000560000_5.1.e002347.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31140-7"},{"key":"2026061205000560000_5.1.e002347.2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0317379","article-title":"The current landscape of personalised preventive approaches for non-communicable diseases: A scoping review","volume":"20","author":"Farina","year":"2025","journal-title":"PLoS One"},{"key":"2026061205000560000_5.1.e002347.3","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1002\/cncr.31382","article-title":"Analyzing the clinical actionability of germline pharmacogenomic findings in oncology","volume":"124","author":"Wellmann","year":"2018","journal-title":"Cancer"},{"key":"2026061205000560000_5.1.e002347.4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/cncr.34104","article-title":"Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing","volume":"128","author":"Reizine","year":"2022","journal-title":"Cancer"},{"key":"2026061205000560000_5.1.e002347.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02401-9"},{"key":"2026061205000560000_5.1.e002347.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03420-w"},{"key":"2026061205000560000_5.1.e002347.7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.23.02225","article-title":"Germline Testing in Patients With Breast Cancer: ASCO\u2013Society of Surgical Oncology Guideline","volume":"42","author":"Bedrosian","year":"2024","journal-title":"JCO"},{"key":"2026061205000560000_5.1.e002347.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.05.044"},{"key":"2026061205000560000_5.1.e002347.9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MOL.0000000000000759","article-title":"Polygenic risk scores: how much do they add?","volume":"32","author":"Christoffersen","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"2026061205000560000_5.1.e002347.10","doi-asserted-by":"crossref","first-page":"100803","DOI":"10.1016\/j.gim.2023.100803","article-title":"The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Abu-El-Haija","year":"2023","journal-title":"Genet Med"},{"key":"2026061205000560000_5.1.e002347.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03243-6"},{"key":"2026061205000560000_5.1.e002347.12","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa136"},{"key":"2026061205000560000_5.1.e002347.13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","article-title":"Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers","volume":"26","author":"Mars","year":"2020","journal-title":"Nat Med"},{"key":"2026061205000560000_5.1.e002347.14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1919976117"},{"key":"2026061205000560000_5.1.e002347.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.07.006"},{"key":"2026061205000560000_5.1.e002347.16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jand.2020.04.001","article-title":"Effect of Incorporating Genetic Testing Results into Nutrition Counseling and Care on Dietary Intake: An Evidence Analysis Center Systematic Review-Part I","volume":"121","author":"Robinson","year":"2021","journal-title":"J Acad Nutr Diet"},{"key":"2026061205000560000_5.1.e002347.17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jand.2020.02.009","article-title":"Effect of Incorporating Genetic Testing Results into Nutrition Counseling and Care on Health Outcomes: An Evidence Analysis Center Systematic Review-Part II","volume":"121","author":"Ellis","year":"2021","journal-title":"J Acad Nutr Diet"},{"key":"2026061205000560000_5.1.e002347.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i1102","article-title":"The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis","volume":"352","author":"Hollands","year":"2016","journal-title":"BMJ"},{"key":"2026061205000560000_5.1.e002347.19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000488086","article-title":"A Systematic Review of Genetic Testing and Lifestyle Behaviour Change: Are We Using High-Quality Genetic Interventions and Considering Behaviour Change Theory?","volume":"11","author":"Horne","year":"2018","journal-title":"Lifestyle Genom"},{"key":"2026061205000560000_5.1.e002347.20","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114516002488"},{"key":"2026061205000560000_5.1.e002347.21","doi-asserted-by":"crossref","unstructured":"Russo L , Perilli A , Pastorino R , et al . A systematic review and meta-analysis of randomized trials on the efficacy of genetic risk information on behavioral change, therapy adherence and clinical outcomes. OSF Preprints; 2024. doi:10.17605\/OSF.IO\/7TEBU","DOI":"10.1093\/eurpub\/ckae144.1962"},{"key":"2026061205000560000_5.1.e002347.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026061205000560000_5.1.e002347.23","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106763"},{"key":"2026061205000560000_5.1.e002347.24","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.818574","article-title":"Calculating Polygenic Risk Scores (PRS) in UK Biobank: A Practical Guide for Epidemiologists","volume":"13","author":"Collister","year":"2022","journal-title":"Front Genet"},{"key":"2026061205000560000_5.1.e002347.25","unstructured":"National Cancer Institute . NCI dictionary of genetics terms: prs. n.d. [cited 2026 Jun 4] Available: https:\/\/www.cancer.gov\/publications\/dictionaries\/genetics-dictionary\/def\/prs"},{"key":"2026061205000560000_5.1.e002347.26","unstructured":"Moorthie S , Babb de Villiers C , Brigden T , et al . Polygenic Scores, Risk and Cardiovascular Disease, ISBN978-1-907198-35-9. Cambridge, UK: PHG Foundation, 2019."},{"key":"2026061205000560000_5.1.e002347.27","doi-asserted-by":"crossref","unstructured":"Cao C , Arora R , Cento p , et al . Automation of systematic reviews with large language models. medRxiv 2025. doi:10.1101\/2025.06.13.25329541","DOI":"10.1101\/2025.06.13.25329541"},{"key":"2026061205000560000_5.1.e002347.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026061205000560000_5.1.e002347.29","doi-asserted-by":"publisher","DOI":"10.2307\/1164588"},{"key":"2026061205000560000_5.1.e002347.30","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183"},{"key":"2026061205000560000_5.1.e002347.31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary","volume":"11","author":"Shi","year":"2020","journal-title":"Res Synth Methods"},{"key":"2026061205000560000_5.1.e002347.32","doi-asserted-by":"publisher","DOI":"10.1177\/09622802231172043"},{"key":"2026061205000560000_5.1.e002347.33","doi-asserted-by":"publisher","DOI":"10.3102\/10769986030003261"},{"key":"2026061205000560000_5.1.e002347.34","doi-asserted-by":"crossref","unstructured":"Woodward M . Epidemiology: study design and data analysis. Chapman and Hall\/CRC, 2013.","DOI":"10.1201\/b16343"},{"key":"2026061205000560000_5.1.e002347.35","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.881349","article-title":"Psychosocial Effects of Receiving Genome-Wide Polygenic Risk Information Concerning Type 2 Diabetes and Coronary Heart Disease: A Randomized Controlled Trial","volume":"13","author":"Halmesvaara","year":"2022","journal-title":"Front Genet"},{"key":"2026061205000560000_5.1.e002347.36","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.pec.2015.06.016","article-title":"Effects of provision of type 2 diabetes genetic risk feedback on patient perceptions of diabetes control and diet and physical activity self-efficacy","volume":"98","author":"McVay","year":"2015","journal-title":"Patient Educ Couns"},{"key":"2026061205000560000_5.1.e002347.37","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.115.129049"},{"key":"2026061205000560000_5.1.e002347.38","doi-asserted-by":"crossref","unstructured":"Celis-Morales C , Livingstone KM , Marsaux CFM , et al . Effect of personalized nutrition on health-related behaviour change: evidence from the Food4me European randomized controlled trial. Int J Epidemiol 2016;dyw186. doi:10.1093\/ije\/dyw186","DOI":"10.1093\/ije\/dyw186"},{"key":"2026061205000560000_5.1.e002347.39","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1793"},{"key":"2026061205000560000_5.1.e002347.40","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s11606-019-05126-z","article-title":"Associations of Diabetes Genetic Risk Counseling with Incident Diabetes and Weight: 5-Year Follow-up of a Randomized Controlled Trial","volume":"35","author":"Raghavan","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2026061205000560000_5.1.e002347.41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.124.004968","article-title":"Effect of Disclosing a Polygenic Risk Score for Coronary Heart Disease on Adverse Cardiovascular Events","volume":"18","author":"Naderian","year":"2025","journal-title":"Circ Genom Precis Med"},{"key":"2026061205000560000_5.1.e002347.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112665","article-title":"Disclosure of genetic information and change in dietary intake: a randomized controlled trial","volume":"9","author":"Nielsen","year":"2014","journal-title":"PLoS One"},{"key":"2026061205000560000_5.1.e002347.43","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0765"},{"key":"2026061205000560000_5.1.e002347.44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000371743","article-title":"An Intervention Study of Individual, apoE Genotype-Based Dietary and Physical-Activity Advice: Impact on Health Behavior","volume":"7","author":"Hietaranta-Luoma","year":"2015","journal-title":"Lifestyle Genomics"},{"key":"2026061205000560000_5.1.e002347.45","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s11606-015-3315-5","article-title":"Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans","volume":"30","author":"Voils","year":"2015","journal-title":"J Gen Intern Med"},{"key":"2026061205000560000_5.1.e002347.46","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.rec.2016.06.017","article-title":"Awareness of Genetic Coronary Risk Score Improves Blood Pressure Control in Hypertensive Patients","volume":"69","author":"Dom\u00e9nech","year":"2016","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"2026061205000560000_5.1.e002347.47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10897-016-9988-z","article-title":"Impact of Genetic Testing and Family Health History Based Risk Counseling on Behavior Change and Cognitive Precursors for Type 2 Diabetes","volume":"26","author":"Wu","year":"2017","journal-title":"J Genet Couns"},{"key":"2026061205000560000_5.1.e002347.48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000510216","article-title":"Can a Lifestyle Genomics Intervention Motivate Patients to Engage in Greater Physical Activity than a Population-Based Intervention? Results from the NOW Randomized Controlled Trial","volume":"13","author":"Horne","year":"2020","journal-title":"Lifestyle Genom"},{"key":"2026061205000560000_5.1.e002347.49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133143","article-title":"A Randomized Trial of Precision Prevention Materials to Improve Primary and Secondary Melanoma Prevention Activities among Individuals with Limited Melanoma Risk Phenotypes","volume":"13","author":"Lacson","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026061205000560000_5.1.e002347.50","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182312333","article-title":"Does Direct-to-Consumer Personal Genetic Testing Improve Gynecological Cancer Screening Uptake among Never-Screened Attendees? A Randomized Controlled Study","volume":"18","author":"Watanabe","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026061205000560000_5.1.e002347.51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/2767-9764.CRC-21-0114","article-title":"A randomized clinical trial of precision prevention materials incorporating MC1R genetic risk to improve skin cancer prevention activities among Hispanics","volume":"2","author":"Lacson","year":"2022","journal-title":"Cancer Res Commun"},{"key":"2026061205000560000_5.1.e002347.52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1037\/hea0001183","article-title":"Health coaching and genetic risk testing in primary care: Randomized controlled trial","volume":"41","author":"Wolever","year":"2022","journal-title":"Health Psychol"},{"key":"2026061205000560000_5.1.e002347.53","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s13187-022-02232-1","article-title":"Increasing Skin Cancer Prevention in Young Adults: the Cumulative Impact of Personalized UV Photography and MC1R Genetic Testing","volume":"38","author":"Wu","year":"2023","journal-title":"J Canc Educ"},{"key":"2026061205000560000_5.1.e002347.54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12687-025-00790-7","article-title":"The impact of supplementing traditional risk information with polygenic risk score concerning type 2 diabetes and coronary heart disease on health behavior: a randomized controlled trial","volume":"16","author":"Halmesvaara","year":"2025","journal-title":"J Community Genet"},{"key":"2026061205000560000_5.1.e002347.55","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2017.00053","article-title":"Impact of a Genetic Risk Score for Coronary Artery Disease on Reducing Cardiovascular Risk: A Pilot Randomized Controlled Study","volume":"4","author":"Knowles","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"2026061205000560000_5.1.e002347.56","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-024-03422-y","article-title":"Effectiveness of genetic feedback on alcohol metabolism to reduce alcohol consumption in young adults: an open-label randomized controlled trial","volume":"22","author":"Owaki","year":"2024","journal-title":"BMC Med"},{"key":"2026061205000560000_5.1.e002347.57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291052","article-title":"Changes in anxiety and depression levels and meat intake following recognition of low genetic risk for high body mass index, triglycerides, and lipoproteins: A randomized controlled trial","volume":"18","author":"Lee","year":"2023","journal-title":"PLoS One"},{"key":"2026061205000560000_5.1.e002347.58","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeac079","article-title":"Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot study","volume":"2","author":"Viigimaa","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2026061205000560000_5.1.e002347.59","doi-asserted-by":"crossref","first-page":"109969","DOI":"10.1016\/j.diabres.2022.109969","article-title":"A randomized clinical trial of genetic testing and personalized risk counselling in patients with type 2 diabetes receiving integrated care -The genetic testing and patient empowerment (GEM) trial","volume":"189","author":"Ma","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2026061205000560000_5.1.e002347.60","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0395"},{"key":"2026061205000560000_5.1.e002347.61","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-314211"},{"key":"2026061205000560000_5.1.e002347.62","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01292-w"},{"key":"2026061205000560000_5.1.e002347.63","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-017-2831-2","article-title":"Using a genetic\/clinical risk score to stop smoking (GeTSS): randomised controlled trial","volume":"10","author":"Nichols","year":"2017","journal-title":"BMC Res Notes"},{"key":"2026061205000560000_5.1.e002347.64","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020109"},{"key":"2026061205000560000_5.1.e002347.65","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1002\/cncr.30162","article-title":"Randomized trial finds that prostate cancer genetic risk score feedback targets prostate\u2010specific antigen screening among at\u2010risk men","volume":"122","author":"Turner","year":"2016","journal-title":"Cancer"},{"key":"2026061205000560000_5.1.e002347.66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002185","article-title":"Lifestyle Advice Combined with Personalized Estimates of Genetic or Phenotypic Risk of Type 2 Diabetes, and Objectively Measured Physical Activity: A Randomized Controlled Trial","volume":"13","author":"Godino","year":"2016","journal-title":"PLoS Med"},{"key":"2026061205000560000_5.1.e002347.67","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0884"},{"key":"2026061205000560000_5.1.e002347.68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/bmjnph-2020-000073","article-title":"Enhanced long-term dietary change and adherence in a nutrigenomics-guided lifestyle intervention compared to a population-based (GLB\/DPP) lifestyle intervention for weight management: results from the NOW randomised controlled trial","volume":"3","author":"Horne","year":"2020","journal-title":"BMJ Nutr Prev Health"},{"key":"2026061205000560000_5.1.e002347.69","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-6-29"},{"key":"2026061205000560000_5.1.e002347.70","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/eurjpc\/zwaf014","article-title":"Genetic risk disclosure and behavioural change: not so fast","volume":"33","author":"Naderian","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"2026061205000560000_5.1.e002347.71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/eurjpc\/zwae362","article-title":"Impact of genetic risk information for cardiovascular disease on behavioural changes, psychological responses and risk factor modification: a systematic review","volume":"33","author":"Chen","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"2026061205000560000_5.1.e002347.72","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-022-01117-8","article-title":"Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization","volume":"14","author":"Lewis","year":"2022","journal-title":"Genome Med"},{"key":"2026061205000560000_5.1.e002347.73","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-024-01747-z"},{"key":"2026061205000560000_5.1.e002347.74","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamainternmed.2022.3171","article-title":"Incremental Value of Polygenic Risk Scores in Primary Prevention of Coronary Heart Disease: A Review","volume":"182","author":"Groenendyk","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2026061205000560000_5.1.e002347.75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gim.2022.09.008","article-title":"Models of communication for polygenic scores and associated psychosocial and behavioral effects on recipients: A systematic review","volume":"25","author":"Wallingford","year":"2023","journal-title":"Genet Med"},{"key":"2026061205000560000_5.1.e002347.76","doi-asserted-by":"crossref","unstructured":"Wid\u00e9n E , Junna N , Ruotsalainen S , et al . How Communicating Polygenic and Clinical Risk for Atherosclerotic Cardiovascular Disease Impacts Health Behavior: an Observational Follow-up Study. Circ: Genomic and Precision Medicine 2022;15. doi:10.1161\/CIRCGEN.121.003459","DOI":"10.1161\/CIRCGEN.121.003459"},{"key":"2026061205000560000_5.1.e002347.77","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.21782"},{"key":"2026061205000560000_5.1.e002347.78","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22241"},{"key":"2026061205000560000_5.1.e002347.79","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s41562-025-02200-x","article-title":"Psychological and behavioural considerations for integrating polygenic risk scores for disease into clinical practice","volume":"9","author":"Sanderson","year":"2025","journal-title":"Nat Hum Behav"},{"key":"2026061205000560000_5.1.e002347.80","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000554","article-title":"Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog","volume":"2","author":"Hingorani","year":"2023","journal-title":"BMJ Med"},{"key":"2026061205000560000_5.1.e002347.81","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073149","article-title":"Realistic expectations are key to realising the benefits of polygenic scores","volume":"380","author":"Sud","year":"2023","journal-title":"BMJ"},{"key":"2026061205000560000_5.1.e002347.82","doi-asserted-by":"crossref","DOI":"10.1038\/s44325-025-00049-7","article-title":"Polygenic risk scores improve CAD risk prediction in individuals at borderline and intermediate clinical risk","volume":"2","author":"Ratman","year":"2025","journal-title":"NPJ Cardiovasc Health"},{"key":"2026061205000560000_5.1.e002347.83","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae342"},{"key":"2026061205000560000_5.1.e002347.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2024.10.010"},{"key":"2026061205000560000_5.1.e002347.85","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41588-024-01843-2","article-title":"Promoting equity in polygenic risk assessment through global collaboration","volume":"56","author":"Kullo","year":"2024","journal-title":"Nat Genet"},{"key":"2026061205000560000_5.1.e002347.86","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajhg.2025.05.012","article-title":"Weighing the evidence on costs and benefits of polygenic risk-based approaches in clinical practice: A systematic review of economic evaluations","volume":"112","author":"Siena","year":"2025","journal-title":"Am J Hum Genet"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2025-002347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:00:26Z","timestamp":1781265626000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2025-002347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,12]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjmed-2025-002347"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2025-002347","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}